American Century Companies Inc. Purchases 134,205 Shares of Plexus Corp. $PLXS

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

American Century Companies Inc. lifted its holdings in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 24.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 678,222 shares of the technology company's stock after acquiring an additional 134,205 shares during the quarter. American Century Companies Inc. owned 2.50% of Plexus worth $86,901,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in PLXS. Aquatic Capital Management LLC raised its stake in shares of Plexus by 134.0% in the fourth quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock valued at $37,000 after buying an additional 134 shares during the period. Versant Capital Management Inc raised its stake in shares of Plexus by 1,000.0% in the first quarter. Versant Capital Management Inc now owns 473 shares of the technology company's stock valued at $61,000 after buying an additional 430 shares during the period. TD Private Client Wealth LLC raised its stake in shares of Plexus by 185.6% in the first quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company's stock valued at $66,000 after buying an additional 334 shares during the period. N.E.W. Advisory Services LLC bought a new stake in shares of Plexus in the first quarter valued at $87,000. Finally, Blue Trust Inc. raised its stake in shares of Plexus by 49.2% in the first quarter. Blue Trust Inc. now owns 846 shares of the technology company's stock valued at $108,000 after buying an additional 279 shares during the period. 94.45% of the stock is currently owned by institutional investors.

Plexus Price Performance

Plexus stock traded up $6.71 during midday trading on Friday, hitting $137.26. 151,618 shares of the company's stock were exchanged, compared to its average volume of 180,705. Plexus Corp. has a 52-week low of $103.43 and a 52-week high of $172.89. The stock has a 50-day moving average price of $132.44 and a two-hundred day moving average price of $130.15. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.58. The company has a market cap of $3.70 billion, a P/E ratio of 23.38 and a beta of 0.80.

Plexus (NASDAQ:PLXS - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.71 by $0.19. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The business had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.02 billion. During the same period in the previous year, the business earned $1.45 earnings per share. The firm's revenue was up 6.0% on a year-over-year basis. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, equities research analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current year.

Insider Buying and Selling at Plexus

In related news, CFO Patrick John Jermain sold 2,178 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $130.42, for a total transaction of $284,054.76. Following the completion of the transaction, the chief financial officer directly owned 23,459 shares in the company, valued at $3,059,522.78. The trade was a 8.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Angelo Michael Ninivaggi, Jr. sold 2,058 shares of the business's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $132.22, for a total value of $272,108.76. Following the transaction, the chief accounting officer owned 26,133 shares of the company's stock, valued at approximately $3,455,305.26. The trade was a 7.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 12,484 shares of company stock valued at $1,626,335 over the last 90 days. Insiders own 1.76% of the company's stock.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Benchmark restated a "buy" rating and issued a $160.00 target price on shares of Plexus in a research note on Wednesday, June 4th. Sidoti upgraded Plexus from a "neutral" rating to a "buy" rating and boosted their target price for the company from $135.00 to $150.00 in a research note on Friday, July 25th. Wall Street Zen cut Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th. Stifel Nicolaus set a $140.00 price target on Plexus in a research report on Thursday, July 24th. Finally, Needham & Company LLC reduced their price target on Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research report on Thursday, July 24th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $152.00.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.